Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer

Details for Australian Patent Application No. 2008338204 (hide)

Owner Prometic Biosciences Inc.

Inventors Gagnon, Lyne; Penney, Christopher; Geerts, Lilianne

Agent Cullens

Pub. Number AU-A-2008338204

PCT Pub. Number WO2009/076761

Priority 61/008,129 19.12.07 US

Filing date 18 December 2008

Wipo publication date 25 June 2009

International Classifications

A61K 31/7068 (2006.01)

A61K 31/20 (2006.01)

A61K 31/23 (2006.01)

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 July 2010 PCT application entered the National Phase

  PCT publication WO2009/076761 Priority application(s): WO2009/076761

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008338205-Dryer for fuel material

2008338202-Automated order sequencing method and system